APO Research
Talk to an analyst

APO RESEARCH · REPORT

Primidone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Primidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchPrimidone Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Primidone Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Primidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Primidone Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Primidone Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Primidone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Primidone include Amneal Pharm, Anda Repository, Dr Reddys Laboratories, Hikma Intl Pharms, Impax Laboratories, Lannett, Mutual Pharmaceutical, Oxford Pharms and Valeant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Primidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Primidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Primidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Primidone market size, projected growth trends, production technologies, key applications, and end-use industries.

Primidone Segment by Company

Amneal Pharm

Anda Repository

Dr Reddys Laboratories

Hikma Intl Pharms

Impax Laboratories

Lannett

Mutual Pharmaceutical

Oxford Pharms

Valeant

Valeant Pharmaceuticals International

Vintage Pharmaceuticals

Watson Labs

West Ward Pharmaceutical

Xcel Pharmaceuticals

Primidone Segment by Type

50mg

250mg

Primidone Segment by Application

Epilepsy

Psychiatric Disorders

Essential Tremor

Primidone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Primidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Primidone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Primidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Primidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Primidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Primidone Industry Trends Table 2. Primidone Industry Drivers Table 3. Primidone Industry Opportunities and Challenges Table 4. Primidone Industry Restraints Table 5. Global Primidone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Primidone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Primidone Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Primidone Sales Market Share by Manufacturers Table 9. Global Primidone Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Primidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Primidone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Primidone Manufacturers, Product Type & Application Table 13. Global Primidone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Primidone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50mg Table 17. Major Manufacturers of 250mg Table 18. Global Primidone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Primidone Sales by Type (2021-2026) & (K Units) Table 20. Global Primidone Sales by Type (2027-2032) & (K Units) Table 21. Global Primidone Sales Market Share by Type (2021-2026) Table 22. Global Primidone Sales Market Share by Type (2027-2032) Table 23. Global Primidone Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Primidone Revenue by Type (2021-2026) & (K Units) Table 25. Global Primidone Revenue by Type (2027-2032) & (K Units) Table 26. Global Primidone Revenue Market Share by Type (2021-2026) Table 27. Global Primidone Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Epilepsy Table 29. Major Manufacturers of Psychiatric Disorders Table 30. Major Manufacturers of Essential Tremor Table 31. Global Primidone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Primidone Sales by Application (2021-2026) & (K Units) Table 33. Global Primidone Sales by Application (2027-2032) & (K Units) Table 34. Global Primidone Sales Market Share by Application (2021-2026) Table 35. Global Primidone Sales Market Share by Application (2027-2032) Table 36. Global Primidone Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Primidone Revenue by Application (2021-2026) & (K Units) Table 38. Global Primidone Revenue by Application (2027-2032) & (K Units) Table 39. Global Primidone Revenue Market Share by Application (2021-2026) Table 40. Global Primidone Revenue Market Share by Application (2027-2032) Table 41. Global Primidone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Primidone Sales by Region (2021-2026) & (K Units) Table 43. Global Primidone Sales Market Share by Region (2021-2026) Table 44. Global Primidone Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Primidone Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Primidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Primidone Sales by Country (2021-2026) & (K Units) Table 48. North America Primidone Sales by Country (2027-2032) & (K Units) Table 49. Europe Primidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Primidone Sales by Country (2021-2026) & (K Units) Table 51. Europe Primidone Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Primidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Primidone Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Primidone Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Primidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Primidone Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Primidone Sales by Country (2027-2032) & (K Units) Table 58. Global Primidone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Primidone Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Primidone Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Primidone Revenue Market Share by Region (2021-2026) Table 62. Global Primidone Revenue Market Share by Region (2027-2032) Table 63. Amneal Pharm Company Information Table 64. Amneal Pharm Business Overview Table 65. Amneal Pharm Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Amneal Pharm Primidone Product Portfolio Table 67. Amneal Pharm Recent Development Table 68. Anda Repository Company Information Table 69. Anda Repository Business Overview Table 70. Anda Repository Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Anda Repository Primidone Product Portfolio Table 72. Anda Repository Recent Development Table 73. Dr Reddys Laboratories Company Information Table 74. Dr Reddys Laboratories Business Overview Table 75. Dr Reddys Laboratories Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Dr Reddys Laboratories Primidone Product Portfolio Table 77. Dr Reddys Laboratories Recent Development Table 78. Hikma Intl Pharms Company Information Table 79. Hikma Intl Pharms Business Overview Table 80. Hikma Intl Pharms Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hikma Intl Pharms Primidone Product Portfolio Table 82. Hikma Intl Pharms Recent Development Table 83. Impax Laboratories Company Information Table 84. Impax Laboratories Business Overview Table 85. Impax Laboratories Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Impax Laboratories Primidone Product Portfolio Table 87. Impax Laboratories Recent Development Table 88. Lannett Company Information Table 89. Lannett Business Overview Table 90. Lannett Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lannett Primidone Product Portfolio Table 92. Lannett Recent Development Table 93. Mutual Pharmaceutical Company Information Table 94. Mutual Pharmaceutical Business Overview Table 95. Mutual Pharmaceutical Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Mutual Pharmaceutical Primidone Product Portfolio Table 97. Mutual Pharmaceutical Recent Development Table 98. Oxford Pharms Company Information Table 99. Oxford Pharms Business Overview Table 100. Oxford Pharms Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Oxford Pharms Primidone Product Portfolio Table 102. Oxford Pharms Recent Development Table 103. Valeant Company Information Table 104. Valeant Business Overview Table 105. Valeant Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Valeant Primidone Product Portfolio Table 107. Valeant Recent Development Table 108. Valeant Pharmaceuticals International Company Information Table 109. Valeant Pharmaceuticals International Business Overview Table 110. Valeant Pharmaceuticals International Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Valeant Pharmaceuticals International Primidone Product Portfolio Table 112. Valeant Pharmaceuticals International Recent Development Table 113. Vintage Pharmaceuticals Company Information Table 114. Vintage Pharmaceuticals Business Overview Table 115. Vintage Pharmaceuticals Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Vintage Pharmaceuticals Primidone Product Portfolio Table 117. Vintage Pharmaceuticals Recent Development Table 118. Watson Labs Company Information Table 119. Watson Labs Business Overview Table 120. Watson Labs Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Watson Labs Primidone Product Portfolio Table 122. Watson Labs Recent Development Table 123. West Ward Pharmaceutical Company Information Table 124. West Ward Pharmaceutical Business Overview Table 125. West Ward Pharmaceutical Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. West Ward Pharmaceutical Primidone Product Portfolio Table 127. West Ward Pharmaceutical Recent Development Table 128. Xcel Pharmaceuticals Company Information Table 129. Xcel Pharmaceuticals Business Overview Table 130. Xcel Pharmaceuticals Primidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Xcel Pharmaceuticals Primidone Product Portfolio Table 132. Xcel Pharmaceuticals Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Primidone Distributors List Table 136. Primidone Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Primidone Product Image Figure 2. Global Primidone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Primidone Market Size (2021-2032) & (US$ Million) Figure 4. Global Primidone Sales (2021-2032) & (K Units) Figure 5. Global Primidone Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Primidone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50mg Image Figure 9. 250mg Image Figure 10. Global Primidone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Primidone Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Primidone Sales Market Share by Type (2021-2032) Figure 13. Global Primidone Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Primidone Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Primidone Revenue Market Share by Type (2021-2032) Figure 16. Epilepsy Image Figure 17. Psychiatric Disorders Image Figure 18. Essential Tremor Image Figure 19. Global Primidone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Primidone Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Primidone Sales Market Share by Application (2021-2032) Figure 22. Global Primidone Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Primidone Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Primidone Revenue Market Share by Application (2021-2032) Figure 25. North America Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Primidone Sales Market Share by Country (2021-2032) Figure 27. U.S. Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Primidone Sales Market Share by Country (2021-2032) Figure 32. Germany Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Primidone Sales Market Share by Country (2021-2032) Figure 39. China Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Primidone Sales Market Share by Country (2021-2032) Figure 47. Brazil Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Primidone Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Primidone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Primidone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Primidone Revenue (2021-2032) & (US$ Million) Figure 58. North America Primidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Primidone Revenue (2021-2032) & (US$ Million) Figure 60. Europe Primidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Primidone Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Primidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Primidone Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Primidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Primidone Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Primidone Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 250mg
Applications
  • Epilepsy
  • Psychiatric Disorders
  • Essential Tremor
Companies covered
  • Amneal Pharm
  • Anda Repository
  • Dr Reddys Laboratories
  • Hikma Intl Pharms
  • Impax Laboratories
  • Lannett
  • Mutual Pharmaceutical
  • Oxford Pharms
  • Valeant
  • Valeant Pharmaceuticals International
  • Vintage Pharmaceuticals
  • Watson Labs
  • West Ward Pharmaceutical
  • Xcel Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Primidone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Primidone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Primidone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Primidone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Primidone Market Dynamics
  1. 2.1 Primidone Industry Trends
  2. 2.2 Primidone Industry Drivers
  3. 2.3 Primidone Industry Opportunities and Challenges
  4. 2.4 Primidone Industry Restraints
3 Primidone Market by Manufacturers
  1. 3.1 Global Primidone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Primidone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Primidone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Primidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Primidone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Primidone Manufacturers, Product Type & Application
  7. 3.7 Global Primidone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Primidone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Primidone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Primidone Tier 1, Tier 2, and Tier 3
4 Primidone Market by Type
  1. 4.1 Primidone Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 250mg
  4. 4.2 Global Primidone Sales by Type
  5. 4.2.1 Global Primidone Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Primidone Sales by Type (2021-2032)
  7. 4.2.3 Global Primidone Sales Market Share by Type (2021-2032)
  8. 4.3 Global Primidone Revenue by Type
  9. 4.3.1 Global Primidone Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Primidone Revenue by Type (2021-2032)
  11. 4.3.3 Global Primidone Revenue Market Share by Type (2021-2032)
5 Primidone Market by Application
  1. 5.1 Primidone Application Introduction
  2. 5.1.1 Epilepsy
  3. 5.1.2 Psychiatric Disorders
  4. 5.1.3 Essential Tremor
  5. 5.2 Global Primidone Sales by Application
  6. 5.2.1 Global Primidone Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Primidone Sales by Application (2021-2032)
  8. 5.2.3 Global Primidone Sales Market Share by Application (2021-2032)
  9. 5.3 Global Primidone Revenue by Application
  10. 5.3.1 Global Primidone Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Primidone Revenue by Application (2021-2032)
  12. 5.3.3 Global Primidone Revenue Market Share by Application (2021-2032)
6 Global Primidone Sales by Region
  1. 6.1 Global Primidone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Primidone Sales by Region (2021-2032)
  3. 6.2.1 Global Primidone Sales by Region (2021-2026)
  4. 6.2.2 Global Primidone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Primidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Primidone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Primidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Primidone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Primidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Primidone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Primidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Primidone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Primidone Revenue by Region
  1. 7.1 Global Primidone Revenue by Region
  2. 7.1.1 Global Primidone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Primidone Revenue by Region (2021-2026)
  4. 7.1.3 Global Primidone Revenue by Region (2027-2032)
  5. 7.1.4 Global Primidone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Primidone Revenue (2021-2032)
  8. 7.2.2 North America Primidone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Primidone Revenue (2021-2032)
  11. 7.3.2 Europe Primidone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Primidone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Primidone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Primidone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Primidone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Amneal Pharm
  2. 8.1.1 Amneal Pharm Company Information
  3. 8.1.2 Amneal Pharm Business Overview
  4. 8.1.3 Amneal Pharm Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Amneal Pharm Primidone Product Portfolio
  6. 8.1.5 Amneal Pharm Recent Developments
  7. 8.2 Anda Repository
  8. 8.2.1 Anda Repository Company Information
  9. 8.2.2 Anda Repository Business Overview
  10. 8.2.3 Anda Repository Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Anda Repository Primidone Product Portfolio
  12. 8.2.5 Anda Repository Recent Developments
  13. 8.3 Dr Reddys Laboratories
  14. 8.3.1 Dr Reddys Laboratories Company Information
  15. 8.3.2 Dr Reddys Laboratories Business Overview
  16. 8.3.3 Dr Reddys Laboratories Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dr Reddys Laboratories Primidone Product Portfolio
  18. 8.3.5 Dr Reddys Laboratories Recent Developments
  19. 8.4 Hikma Intl Pharms
  20. 8.4.1 Hikma Intl Pharms Company Information
  21. 8.4.2 Hikma Intl Pharms Business Overview
  22. 8.4.3 Hikma Intl Pharms Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hikma Intl Pharms Primidone Product Portfolio
  24. 8.4.5 Hikma Intl Pharms Recent Developments
  25. 8.5 Impax Laboratories
  26. 8.5.1 Impax Laboratories Company Information
  27. 8.5.2 Impax Laboratories Business Overview
  28. 8.5.3 Impax Laboratories Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Impax Laboratories Primidone Product Portfolio
  30. 8.5.5 Impax Laboratories Recent Developments
  31. 8.6 Lannett
  32. 8.6.1 Lannett Company Information
  33. 8.6.2 Lannett Business Overview
  34. 8.6.3 Lannett Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lannett Primidone Product Portfolio
  36. 8.6.5 Lannett Recent Developments
  37. 8.7 Mutual Pharmaceutical
  38. 8.7.1 Mutual Pharmaceutical Company Information
  39. 8.7.2 Mutual Pharmaceutical Business Overview
  40. 8.7.3 Mutual Pharmaceutical Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mutual Pharmaceutical Primidone Product Portfolio
  42. 8.7.5 Mutual Pharmaceutical Recent Developments
  43. 8.8 Oxford Pharms
  44. 8.8.1 Oxford Pharms Company Information
  45. 8.8.2 Oxford Pharms Business Overview
  46. 8.8.3 Oxford Pharms Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Oxford Pharms Primidone Product Portfolio
  48. 8.8.5 Oxford Pharms Recent Developments
  49. 8.9 Valeant
  50. 8.9.1 Valeant Company Information
  51. 8.9.2 Valeant Business Overview
  52. 8.9.3 Valeant Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Valeant Primidone Product Portfolio
  54. 8.9.5 Valeant Recent Developments
  55. 8.10 Valeant Pharmaceuticals International
  56. 8.10.1 Valeant Pharmaceuticals International Company Information
  57. 8.10.2 Valeant Pharmaceuticals International Business Overview
  58. 8.10.3 Valeant Pharmaceuticals International Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Valeant Pharmaceuticals International Primidone Product Portfolio
  60. 8.10.5 Valeant Pharmaceuticals International Recent Developments
  61. 8.11 Vintage Pharmaceuticals
  62. 8.11.1 Vintage Pharmaceuticals Company Information
  63. 8.11.2 Vintage Pharmaceuticals Business Overview
  64. 8.11.3 Vintage Pharmaceuticals Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vintage Pharmaceuticals Primidone Product Portfolio
  66. 8.11.5 Vintage Pharmaceuticals Recent Developments
  67. 8.12 Watson Labs
  68. 8.12.1 Watson Labs Company Information
  69. 8.12.2 Watson Labs Business Overview
  70. 8.12.3 Watson Labs Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Watson Labs Primidone Product Portfolio
  72. 8.12.5 Watson Labs Recent Developments
  73. 8.13 West Ward Pharmaceutical
  74. 8.13.1 West Ward Pharmaceutical Company Information
  75. 8.13.2 West Ward Pharmaceutical Business Overview
  76. 8.13.3 West Ward Pharmaceutical Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 West Ward Pharmaceutical Primidone Product Portfolio
  78. 8.13.5 West Ward Pharmaceutical Recent Developments
  79. 8.14 Xcel Pharmaceuticals
  80. 8.14.1 Xcel Pharmaceuticals Company Information
  81. 8.14.2 Xcel Pharmaceuticals Business Overview
  82. 8.14.3 Xcel Pharmaceuticals Primidone Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Xcel Pharmaceuticals Primidone Product Portfolio
  84. 8.14.5 Xcel Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Primidone Value Chain Analysis
  2. 9.1.1 Primidone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Primidone Production Mode & Process
  6. 9.2 Primidone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Primidone Distributors
  9. 9.2.3 Primidone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst